摩根大通：将葛兰素史克目标价从1500便士上调至1700便士。

Core Viewpoint - Morgan Stanley has raised the target price for GlaxoSmithKline from 1500 pence to 1700 pence [1] Company Summary - The adjustment in target price reflects a positive outlook on GlaxoSmithKline's performance and potential growth [1]